drug information services

Summary

Summary: Services providing pharmaceutic and therapeutic drug information and consultation.

Top Publications

  1. ncbi Ask the pharmacist: an analysis of online drug information services
    Erin R Holmes
    School of Pharmacy, University of Mississippi, University, MS 38677 1848, USA
    Ann Pharmacother 39:662-7. 2005
  2. ncbi Sources of information for new drugs among physicians in Thailand
    Maneerat R Layton
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand
    Pharm World Sci 29:619-27. 2007
  3. ncbi Lactation safety recommendations and reliability compared in 10 medication resources
    Monica Akus
    Department of Pharmacy, Cambridge Health Alliance, Somerville, MA 02143, USA
    Ann Pharmacother 41:1352-60. 2007
  4. ncbi Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction
    Katherine E Waack
    College of Pharmacy, The University of Iowa, Iowa City, IA, USA
    Ann Pharmacother 38:2029-34. 2004
  5. ncbi Do themes in consumer medicines information literature reviews reflect those important to stakeholders?
    Donald J Nicolson
    School of Healthcare, Baines Wing University of Leeds, Leeds LS2 9UT, UK
    Patient Educ Couns 64:112-8. 2006
  6. pmc GPs' thoughts on prescribing medication and evidence-based knowledge: the benefit aspect is a strong motivator. A descriptive focus group study
    Ingmarie Skoglund
    Department of Primary Health Care, The Sahlgrenska Academy at Goteborg University, Sweden
    Scand J Prim Health Care 25:98-104. 2007
  7. ncbi [Evaluation of Brazilian online pharmacies]
    Ana Paula Soares Gondim
    Curso de Farmácia, Universidade de Fortaleza, Av Washington Soares 1321, 60811 905 Fortaleza, CE, Brazil
    Rev Saude Publica 41:297-300. 2007
  8. ncbi Pharmacokinetic studies in pregnant women
    G J Anger
    Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:184-7. 2008
  9. pmc Promotional methods used by representatives of drug companies: a prospective survey in general practice
    Jesper Schramm
    Research Unit for General Practice, University of Southern Denmark, Odense, Denmark
    Scand J Prim Health Care 25:93-7. 2007
  10. pmc Personal digital assistant-based drug information sources: potential to improve medication safety
    Kimberly A Galt
    Department of Pharmacy Practice, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, Nebraska 68178, USA
    J Med Libr Assoc 93:229-36. 2005

Research Grants

Detail Information

Publications182 found, 100 shown here

  1. ncbi Ask the pharmacist: an analysis of online drug information services
    Erin R Holmes
    School of Pharmacy, University of Mississippi, University, MS 38677 1848, USA
    Ann Pharmacother 39:662-7. 2005
    ..Given the growing number of patients seeking consultation on the Internet and the difficulty in regulating online pharmacy providers, an analysis of drug information provided by Internet pharmacies is warranted...
  2. ncbi Sources of information for new drugs among physicians in Thailand
    Maneerat R Layton
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand
    Pharm World Sci 29:619-27. 2007
    ..To determine the sources and the types of information about new drugs that Thai doctors at a teaching hospital perceived as important before prescribing and to assess their views on their preferred sources of drug information...
  3. ncbi Lactation safety recommendations and reliability compared in 10 medication resources
    Monica Akus
    Department of Pharmacy, Cambridge Health Alliance, Somerville, MA 02143, USA
    Ann Pharmacother 41:1352-60. 2007
    ..Mothers and physicians often depend on pharmacists for accurate drug information. Their information is only as good as the sources available to them...
  4. ncbi Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction
    Katherine E Waack
    College of Pharmacy, The University of Iowa, Iowa City, IA, USA
    Ann Pharmacother 38:2029-34. 2004
    ..In traditional direct-to-consumer advertisements, viewers are often referred to a pharmaceutical company Web site for further information...
  5. ncbi Do themes in consumer medicines information literature reviews reflect those important to stakeholders?
    Donald J Nicolson
    School of Healthcare, Baines Wing University of Leeds, Leeds LS2 9UT, UK
    Patient Educ Couns 64:112-8. 2006
    ..To compare the themes emerging from a stakeholder workshop on consumers' medicines information with themes in relevant published reviews...
  6. pmc GPs' thoughts on prescribing medication and evidence-based knowledge: the benefit aspect is a strong motivator. A descriptive focus group study
    Ingmarie Skoglund
    Department of Primary Health Care, The Sahlgrenska Academy at Goteborg University, Sweden
    Scand J Prim Health Care 25:98-104. 2007
    ..To describe GPs' thoughts of prescribing medication and evidence-based knowledge (EBM) concerning drug therapy...
  7. ncbi [Evaluation of Brazilian online pharmacies]
    Ana Paula Soares Gondim
    Curso de Farmácia, Universidade de Fortaleza, Av Washington Soares 1321, 60811 905 Fortaleza, CE, Brazil
    Rev Saude Publica 41:297-300. 2007
    ..Since health control and drug commerce in Brazilian online pharmacies have not been yet regulated by proper government agencies, these gaps found in the sites can pose risk to the users' health...
  8. ncbi Pharmacokinetic studies in pregnant women
    G J Anger
    Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 83:184-7. 2008
    ..The purpose of this report is to highlight this issue and illustrate how current methods used to obtain PK data in pregnancy are insufficient. The steps that are being taken to address this issue will also be discussed...
  9. pmc Promotional methods used by representatives of drug companies: a prospective survey in general practice
    Jesper Schramm
    Research Unit for General Practice, University of Southern Denmark, Odense, Denmark
    Scand J Prim Health Care 25:93-7. 2007
    ..To examine the extent and composition of pharmaceutical industry representatives' marketing techniques with a particular focus on drug sampling in relation to drug age...
  10. pmc Personal digital assistant-based drug information sources: potential to improve medication safety
    Kimberly A Galt
    Department of Pharmacy Practice, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, Nebraska 68178, USA
    J Med Libr Assoc 93:229-36. 2005
    ..This study compared the potential for personal digital assistant (PDA)-based drug information sources to minimize potential medication errors dependent on accurate and complete drug information at the point of care...
  11. pmc Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study
    Christina Edward
    Department of Clinical Pharmacology, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    BMC Clin Pharmacol 7:12. 2007
    ..The objective of the present study was to evaluate if an e-mail with a drug information attachment has effects on sales of prescribed drugs and if the design of the attachment is of importance...
  12. ncbi Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs
    F W May
    Pharmacy Department, Repatriation General Hospital, Daw Park, SA
    Med J Aust 170:471-4. 1999
    ..Exploration of longer-term outcomes of an ongoing educational-outreach service for community doctors...
  13. ncbi Evaluation of drug information databases for personal digital assistants
    Kevin A Clauson
    Nova Southeastern University Drug Information Center, Palm Beach Gardens, FL, USA
    Am J Health Syst Pharm 61:1015-24. 2004
    ..Core and supplemental drug information databases available for use with personal digital assistants (PDAs) were evaluated...
  14. pmc Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree?
    Natalie Kupferberg
    Biological Sciences Pharmacy Library, The Ohio State University, 102 Riffe Building, 496 West 12th Avenue, Columbus, Ohio 43210, USA
    J Med Libr Assoc 92:66-71. 2004
    ..Study findings and recommendations are offered as guidance to librarians responsible for purchasing decisions...
  15. ncbi Advice on drug safety in pregnancy: are there differences between commonly used sources of information?
    Sofia K Frost Widnes
    Regional Drug Information Centre RELIS Vest, Haukeland University Hospital, Bergen, Norway
    Drug Saf 31:799-806. 2008
    ....
  16. pmc What information do physicians receive from pharmaceutical representatives?
    J Lexchin
    Can Fam Physician 43:941-5. 1997
    ..To assess the information pharmaceutical sales representatives provide to physicians...
  17. ncbi [It's possible to influence prescriptions patterns by producer-independent information]
    Sigurd Vitols
    Avdelningen för klinisk farmakologi, Karolinska Universitetssjukhuset Solna, Stockholm, Sweden
    Lakartidningen 101:2573-5. 2004
    ..The finding underlines the need for repeated information when effects on prescription habits are wanted...
  18. ncbi Evaluation of electronic databases used to identify solid oral dosage forms
    Carol G Raschke
    Westside Regional Medical Center, Plantation, FL, USA
    Am J Health Syst Pharm 60:1735-40. 2003
    ..A combination of electronic drug identification databases provides the best method of drug identification in an institutional setting...
  19. ncbi Influence of commercial information on prescription quantity in primary care
    Francisco Caamano
    Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain
    Eur J Public Health 12:187-91. 2002
    ..The objective of this study is to identify the effect of the perceived quality stated in commercial information, its uses, and how physicians perceive the influence it has on prescription amounts...
  20. ncbi Evaluation of online drug references for identifying over-the-counter solid oral dosage forms
    S Jay Weaver
    ACS State Healthcare Atlanta, GA, USA
    J Am Pharm Assoc (2003) 44:694-9. 2004
    ..To evaluate six drug references for their usefulness in identifying over-the-counter (OTC) solid oral dosage forms (SODFs)...
  21. ncbi Drug-information software for Palm operating system personal digital assistants: breadth, clinical dependability, and ease of use
    Shelly J Enders
    Pharmacy Practice Division, St Louis College of Pharmacy, Missouri 63110, USA
    Pharmacotherapy 22:1036-40. 2002
    ..To examine the breadth, clinical dependability, and ease of use of drug-information software programs for personal digital assistants that incorporate the Palm operating system...
  22. ncbi Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?
    Jan Schjøtt
    Regional Drug Information Centre RELIS Vest, Haukeland University Hospital, Bergen, Norway
    Eur J Clin Pharmacol 57:897-902. 2002
    ..In this study our objective was to determine the quality and impact of problem-oriented drug information among physicians...
  23. ncbi Strategies for acquiring affordable medications for seniors
    Kathy J Morris
    Council Bluffs Community Health Center, 300 West Broadway, Suite 6, Council Bluffs, IA, 51503, USA
    Nurs Clin North Am 40:51-62, vi. 2005
    ..Some community healthcenters offer access to prescriptions at decreased costs through fed-eral programs. This article explores the various options availableto senior citizens so that nurses may act as advocates for thesepatients...
  24. ncbi [Public health research with statutory health insurance drug data]
    K Janhsen
    Bremer Institut für Präventionsforschung und Sozialmedizin, Bremen
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:521-5. 2004
    ..This article describes the background and development of using routine data from health insurance companies for scientific purposes and discusses potentials and limitations of such data for public health research...
  25. ncbi Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events
    Gerald N DeLorenze
    Division of Research, Kaiser Permanente, Oakland, California 94602, USA
    Med Care 43:III63-8. 2005
    ..Medication error occurring during the care of HIV-infected patients may lead to treatment failure, drug toxicity, or even death...
  26. ncbi [Prescription errors--dimension and measures]
    Svein Haavik
    Institutt for apotekforskning AS, Kalfarveien 31, 5018 Bergen
    Tidsskr Nor Laegeforen 126:296-8. 2006
    ..The information given on the prescription also forms the basis for reimbursement of drug expenses. Knowledge of prescription errors may improve the procedures of the prescribing physician and the pharmacy...
  27. ncbi [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse]
    A Ben Abdelaziz
    Department of Community Medicine, Faculty of Medicine Ibn El Jazzar, Sousse, Tunisia
    East Mediterr Health J 9:1075-83. 2003
    ..Controlling the validity of the therapeutic information imparted by the pharmaceutical industry is thus a fundamental component of the programme for the rational use of medicines...
  28. ncbi Development of a pharmacy-managed medication dictionary in a newly implemented computerized prescriber order-entry system
    Diane Soulliard
    Department of Pharmacy, Beth Israel Deaconess Medical Center, 1 Deaconess Road, Boston, MA 02215, USA
    Am J Health Syst Pharm 61:617-22. 2004
  29. ncbi Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effects
    J Robert Powell
    Food and Drug Administration, Office of Clinical Pharmacology and Biopharmaceutics, Rockville, Maryland, USA
    Pharmacotherapy 24:422-5. 2004
  30. ncbi Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness
    Bonnie L Svarstad
    School of Pharmacy, University of Wisconsin Madison, Madison 53705, USA
    J Am Pharm Assoc (2003) 44:22-9. 2004
    ....
  31. ncbi [An examination in comparison Web site with other root on the revised information of drug package insert]
    Kiyoshi Okuyama
    Hachioji Medical Center, Tokyo Medical University, Hachioji, Japan
    Yakugaku Zasshi 125:639-42. 2005
    ..From these results, it is suggested that there are variations in the information from each pharmaceutical company on the PMDA site although the site is excellent in terms of comprehensibility...
  32. ncbi Infovigilance: reporting errors in official drug information sources
    Isabelle Fusier
    Centre National Hospitalier d Information sur le Medicament, CNHIM, Hopital Bicetre, 78, rue du General Leclerc, BP 11, 94272, Le Kremlin Bicetre Cedex, France
    Pharm World Sci 27:166-9. 2005
    ..The aim of this study was to evaluate the impact of CNHIM infovigilance on the contents of the Summary of Product Characteristics (SPCs)...
  33. ncbi Innovative solutions: pharmacy and nursing collaboration on a high-risk medication project
    Mary Martin
    Pharmacy Services, Banner Good Samaritan Medical Center, Phoenix, AZ 85006, USA
    Dimens Crit Care Nurs 25:29-32. 2006
    ..The project encompassed policy creation, nursing education, identification and evaluation of HRHA medications, and facility-wide distribution of information related to high-risk and high-alert medications...
  34. ncbi Do pharmacists' reports of adverse drug reactions reflect patients' concerns?
    Kees van Grootheest
    Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH s Hertogenbosch, The Netherlands
    Pharm World Sci 26:155-9. 2004
    ....
  35. ncbi [Clinical pharmacist improves the use of drugs in hospital]
    Piia Pretsch
    Sykehusapotekene ANS, Sykehusapoteket Aker, Trondheimsveien 235, 0514 Oslo
    Tidsskr Nor Laegeforen 124:1923-5. 2004
    ..We investigated how a clinical pharmacist can contribute to quality assurance of the use of drugs for inpatients in a respiratory ward...
  36. ncbi Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care
    Helene Verdoux
    Schizophr Res 77:107-9. 2005
  37. ncbi 2004 AANP National Nurse Practitioner Sample Survey, Part II: nurse practitioner prescribing
    Mary Jo Goolsby
    American Academy of Nurse Practitioners, Austin, TX, USA
    J Am Acad Nurse Pract 17:506-11. 2005
  38. ncbi Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Jisu Huh
    School of Journalism and Mass Communication, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
    J Health Commun 9:529-40. 2004
    ..This study suggests directions for regulators to consider in writing a more specific rule to ensure that information on prescription drug websites is balanced...
  39. ncbi Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing
    Michele M Spence
    Kaiser Permanente, USA
    Med Care Res Rev 62:544-59. 2005
    ..Findings also suggest that some patients may benefit from DTCA. The authors discuss the need for balanced drug information for consumers, increased physician vigilance in prescribing appropriately, and further study of DTCA...
  40. ncbi Implementation of a professional program in Finnish community pharmacies in 2000-2002
    Heli Kansanaho
    Division of Social Pharmacy, Faculty of Pharmacy, University of Helsinki, P O Box 56 Viikinkaari 5 E, 00014 Helsinki, Finland
    Patient Educ Couns 57:272-9. 2005
    ..Future challenges in implementation will be a better commitment of the pharmacy owners to the goals of the national professional strategy and a better access to Internet-based drug information sources while counselling patients...
  41. ncbi Influencing prescribing through effective communication skills
    Shaun F Young
    Harvard Business School, 607 HBS Student Mail Center, Boston, MA 02163, USA
    Am J Health Syst Pharm 62:2528-30. 2005
  42. ncbi Drug recalls and notification of practitioners
    Mary Faut Rodts
    Orthop Nurs 23:353-4. 2004
  43. ncbi Community pharmacy in Australia
    Shalom I Benrimoj
    Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia
    Aust Health Rev 28:238-46. 2004
    ....
  44. ncbi An algorithm to derive a numerical daily dose from unstructured text dosage instructions
    Anoop D Shah
    General Practice Research Database Division, Medicines and Healthcare products Regulatory Agency, London, UK
    Pharmacoepidemiol Drug Saf 15:161-6. 2006
    ..The objective was to develop and assess the validity of an automated algorithm to derive the daily dose from text dosage instructions...
  45. ncbi Analysis of German package inserts
    J Fuchs
    Institute of Clinical Pharmacology, Friedrich Schiller University Jena, Germany
    Int J Clin Pharmacol Ther 44:8-13. 2006
    ..Despite efforts of the European or national regulatory authorities and manufacturers to improve the readability and comprehensiveness of package inserts, they are still the subject of critical discussion...
  46. ncbi [Prescription medicines information: Spanish general population survey]
    X Badia Llach
    Grupo Health Outcomes Research Europe, Barcelona, Spain
    Aten Primaria 36:93-9. 2005
    ..Design. Cross-sectional descriptive study through telephone interviews. Setting. Spanish general population. February-March 2003...
  47. ncbi [Drugs for children--when temporary solutions become routine]
    Betty Kalikstad
    Universitetet i Oslo, Barneklinikken, Rikshospitalet, 0027 Oslo
    Tidsskr Nor Laegeforen 126:930-2. 2006
  48. ncbi Findings from the ISMP Medication Safety Self-Assessment for hospitals
    Judy L Smetzer
    Institute for Safe Medication Practices ISMP, Huntingdon Valley, Pennsylvania, USA
    Jt Comm J Qual Saf 29:586-97. 2003
    ..Hospital medication practices should be assessed, awareness of the characteristics of a safe medication system heightened, and baseline data to identify national priorities established...
  49. ncbi Patient information leaflets--helpful guidance or a source of confusion?
    Lars Bjerrum
    Research Unit of General Practice, University of Southern Denmark, DK 5000 Odense, Denmark
    Pharmacoepidemiol Drug Saf 12:55-9. 2003
    ..Patients may therefore receive different drug information when they renew prescriptions for the same generic drug...
  50. ncbi Optimizing information on drug exposure by collection of package code information in questionnaire surveys
    R Quinzler
    Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany
    Pharmacoepidemiol Drug Saf 16:1024-30. 2007
    ..We aimed to assess the benefit and quality of PZN information collected in self-completed questionnaires...
  51. ncbi Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh
    Shah Amran
    Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi 6205, Bangladesh
    Pak J Pharm Sci 20:327-32. 2007
    ..This study was aimed at examining the extent of the packaging information provided in the secondary packaging items...
  52. ncbi Generics market in Greece: the pharmaceutical industry's beliefs
    Mary Geitona
    Department of Economics, University of Thessaly, 43 Korai Str, Volos 38 221, Greece
    Health Policy 79:35-48. 2006
    ..Finally, the respondents expressed their preference for the introduction of pharmacoeconomic submissions for drugs' reimbursement by social insurance funds...
  53. ncbi [Survival skills in the flood of pharmaceutical information]
    Arja Helin-Salmivaara
    Suomalainen Lääkäriseura Duodecim, ROHTO PL 713, 00101 Helsinki
    Duodecim 118:41-6. 2002
  54. ncbi Pharmaceutical company internet sites as sources of information about antidepressant medications
    Mark A Graber
    Department of Family Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52246, USA
    CNS Drugs 16:419-23. 2002
    ..To determine the informational content of nine pharmaceutical company websites about the antidepressant medication marketed by the company...
  55. ncbi [Written drug information: do patients benefit?]
    Rasmus Rabøl
    H S Bispebjerg Hospital, Klinik I, medicinsk center og klinisk farmakologisk enhed
    Ugeskr Laeger 164:2509-13. 2002
    ..The impact on patient knowledge, satisfaction, and attitude towards taking medicine was examined, as was the patients' evaluation of the information material...
  56. ncbi Electronic prescribing reduces errors and improves patient safety
    Rebel Ward-McKnight
    Arkansas Foundation for Medical Care, USA
    J Ark Med Soc 104:60-1. 2007
  57. ncbi The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Steven Morgan
    Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, V6T 1Z3, Canada
    J Health Serv Res Policy 8:237-44. 2003
    ....
  58. ncbi [Communication and transparency concerning risk-benefit analysis in public health: the example of medication]
    J P Lehner
    , , BP 82, 92355 Le Plessis Robinson, France
    Therapie 56:335-9. 2001
    ..This report summarizes the discussion between the authorities and pharmaceutical companies and reports the different concrete proposals that emerged...
  59. ncbi [Basic study to establish medication safety culture with patient-commitment style in community pharmacy: An examination from meeting reports]
    Mitsuko Onda
    Clinical Laboratory of Practical Pharmacy, Osaka University of Pharmaceutical Sciences, 4 20 1 Nasahara, Takatsuki City 569 1094, Japan
    Yakugaku Zasshi 127:2075-8. 2007
    ....
  60. ncbi [Home visits by a pharmacist after discharge from hospital]
    Synnøve Bergheim
    Sykehusapoteket Lørenskog 1474 Nordbyhagen
    Tidsskr Nor Laegeforen 128:567-9. 2008
    ..This pilot study aims at investigating the feasibility and acceptance of improved written discharge information and home visits (by a pharmacist) to elderly patients who have newly been discharged from a medical department in a hospital...
  61. doi Adverse-drug-event data provided by pharmaceutical companies
    Magdalena E Cudny
    Stanford Hospital and Clinics, Stanford, CA 94304, USA
    Am J Health Syst Pharm 65:1071-5. 2008
    ....
  62. ncbi A defense of the learned intermediary doctrine
    Richard B Goetz
    O Melveny and Myers L L P, Los Angeles, California, USA
    Food Drug Law J 63:421-38. 2008
  63. ncbi Drug promotional practices in Mumbai: a qualitative study
    Nobhojit Roy
    Forum for Medical Ethics, Mumbai, India
    Indian J Med Ethics 4:57-61. 2007
    ..The study also reinforced our impression that medical representatives are the least powerful of the four groups...
  64. ncbi [Information regarding adverse drug effects and treatment indications ("package inserts") exemplified by cervistatin (Lipobay)]
    Robert N Braun
    Arbeitsgemeinschaft zur Erforschung der Allgemeinmedizin, Lüt zowgasse 6 3 21, A 1140 Wien
    Wien Med Wochenschr 153:80-2. 2003
    ..Thus they have to rely on their doctors choice regarding the danger outlined in the inserts. In that respect packing inserts could be improved...
  65. ncbi [The expected role of community pharmacist in society]
    Sei ichiro Hayashi
    Central Pharmaceutical Information Center, Japan Pharmaceutical Association, Nagai Memorial Building 4F, 2 12 15 Shibuya, Shibuya ku, Tokyo 150 8389, Japan
    Yakugaku Zasshi 123:163-71. 2003
    ..In addition, counseling on anxiety and worries about health may be necessary. Bungyo has also affected drug distribution. In this field, the role of community pharmacists in providing drug information may markedly change in the future...
  66. ncbi Institutionwide medication safety program
    Marjorie A Phillips
    Pharmacy Department, Medical College of Georgia Health System, Augusta, GA, USA
    Am J Health Syst Pharm 60:2198-200. 2003
  67. ncbi Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan
    Dileep Kumar Rohra
    Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi, Pakistan
    J Pharm Pharm Sci 9:50-9. 2006
    ..Objectives. To audit the drug promotional claims made by the pharmaceutical companies in Pakistan...
  68. ncbi Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database
    F Michenot
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Centre Hospitalier Universitaire de Toulouse, France
    Pharmacoepidemiol Drug Saf 15:735-40. 2006
    ....
  69. ncbi The information sources used by community nurse prescribers
    Jason Hall
    School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK
    Br J Nurs 12:810-8. 2003
    ..Organizations seeking to influence evidence-based practice should consider the method of communication in addition to the message...
  70. ncbi Producing an information leaflet to help patients access high quality drug information on the Internet: a local study
    Bridget Coleman
    Pharmacy Department, Whittington Hospital, Highgate Hill, London, UK
    Health Info Libr J 20:160-71. 2003
    ..To develop a patient information leaflet (PIL) to help local patients meet their drug information needs using the Internet, and to perform a preliminary evaluation of this tool...
  71. ncbi Introduction to medication errors and the error prevention initiatives in a teaching hospital in Western Nepal
    Arun Kumar Dubey
    Department of Pharmacology, Manipal Teaching Hospital, Manipal College of Medical Sciences, Pokhara, Nepal
    Pak J Pharm Sci 19:244-51. 2006
    ....
  72. ncbi Effects of a national medication education program in Taiwan to change the public's perceptions of the roles and functions of pharmacists
    Ming Fang Wen
    National Taiwan University Hospital, Taipei, Taiwan
    Patient Educ Couns 65:303-10. 2007
    ..To evaluate the effect of a national medication education program on public's perceptions of the roles and functions of pharmacists in Taiwan...
  73. ncbi Paediatric medicines research in the UK: how to move forward?
    Ian Wong
    The School of Pharmacy, University of London, London, United Kingdom
    Drug Saf 26:529-37. 2003
    ..Finally, regulatory authorities, healthcare professionals and academics need to rethink the research strategy in order to provide better medicines for children...
  74. ncbi Contraindication labelling changes in the United States and Germany
    Edeltraut Garbe
    Department of Clinical Pharmacology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Eur J Clin Pharmacol 63:87-93. 2007
    ..Contraindication labelling provides the strongest safety-based guidance for the health care practitioner. In this study, the labelling of new contraindications between the United States (US) and Germany was compared...
  75. ncbi Using the ISMP Medication Safety Self-Assessment to improve medication use processes
    Timothy Lesar
    Albany Medical Center, Albany, New York, USA
    Jt Comm J Qual Saf 29:211-26. 2003
    ....
  76. ncbi German national drug information service: user satisfaction and potential positive patient outcomes
    Thilo Bertsche
    Centre for Drug Information and Pharmacy Practice ZAPP, ABDA Federal Union of German Associations of Pharmacists, Jaegerstrasse 49 50, 10117, Berlin, Germany
    Pharm World Sci 29:167-72. 2007
    ..Our objectives were to assess user's satisfaction with the DIS and to identify any patient-related benefits based on the user's judgment...
  77. ncbi [Computerized decision support in drug prescribing II: A national database to provide up-to-date and unbiased information]
    Lars L Gustafsson
    Avdelningen för klinisk farmakologi, Karolinska Institutet, Huddinge Universitetssjukhus
    Lakartidningen 100:1338-40, 1343-4. 2003
    ....
  78. ncbi Drug information in Zimbabwe: 1990-1999
    Douglas E Ball
    Department of Pharmacy Practice, Faculty of Pharmacy, Health Sciences Center, University of Kuwait, 24923, Safat, 13110, Kuwait
    Pharm World Sci 29:131-6. 2007
    ..To assess the utilisation and development of the Zimbabwe Drug And Toxicology Information Service (DATIS) SETTING: The national drug and poisons information centre in Harare, Zimbabwe...
  79. ncbi [What doctors expect of a pharmacist's work--how a pharmacist is evaluated by doctors]
    Yoshiaki Matsumoto
    Department of Clinical Pharmacology and Toxicology, Showa Pharmaceutical University, 3 3165 Higashitamagawagakuen, Machida, Tokyo 194 8543, Japan
    Yakugaku Zasshi 123:173-8. 2003
    ..In addition, doctors want pharmacists to have more knowledge on pharmacotherapy. These results clearly show what doctors expect of a pharmacist's work...
  80. ncbi Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals
    C A Bond
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center Amarillo, 79106, USA
    Pharmacotherapy 22:134-47. 2002
    ..pharmacy services in the 1081 study hospitals were drug-use evaluation (21,372 more medication errors), drug information services (26,738 fewer medication errors), adverse drug reaction management (44,803 fewer medication errors), ..
  81. ncbi Improving access to computer-based library and drug information services in patient-care areas
    R C Tobia
    Public Services, Briscoe Library, University of Texas Health Science Center, San Antonio 78284
    Am J Hosp Pharm 47:137-42. 1990
    ..Although it is difficult to replace the convenience of an onsite library, at least some drug and biomedical information needs in the clinical setting can be met through computer networking...
  82. ncbi ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004
    Craig A Pedersen
    Division of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210 1291, USA
    Am J Health Syst Pharm 62:378-90. 2005
    ..Results of the 2004 ASHP national survey of pharmacy practice in hospital settings that pertain to prescribing and transcribing are presented...
  83. ncbi Drug information resources in the Veterans Affairs healthcare system
    L M Haynes
    School of Pharmacy, University of Illinois, Chicago, USA
    Hosp Pharm 30:297-301. 1995
    Results of a survey characterizing drug information services and resources from a defined practice area are presented. At the end of 1992, a questionnaire was mailed to 167 Veterans Affairs Medical Centers and Outpatient Clinics...
  84. ncbi A systematic review of the clinical and economic impact of drug information services on patient outcome
    David Hands
    South and West Drug Information Centre, Southampton, UK
    Pharm World Sci 24:132-8. 2002
    ..To establish what is known about the clinical and economic impact of drug information (DI) services on patient outcome...
  85. ncbi Providing nighttime pharmaceutical services through telepharmacy
    Christopher A Keeys
    MedNovations, Inc, 7245 Hanover Parkway, Suite C, Greenbelt, MD 20770, USA
    Am J Health Syst Pharm 59:716-21. 2002
    ..Prospective order review, drug information services, and clinical pharmacy consultations were all provided under the new model...
  86. pmc A pharmacotherapy capstone course to advance pharmacy students' clinical documentation skills
    Jeannine M Conway
    College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
    Am J Pharm Educ 76:134. 2012
    ..The course was intended to improve third-year doctor of pharmacy (PharmD) students' clinical documentation skills in preparation for beginning advanced pharmacy practice experiences (APPEs)...
  87. doi [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness]
    R Leutgeb
    Abteilung Allgemeinmedizin und Versorgungsforschung, Universitatsklinikum Heidelberg, Fürth
    Dtsch Med Wochenschr 134:181-6. 2009
    ..This study aimed at exploring whether patients have been properly informed about the new discount contracts and if they have experienced changes and problems in their long- term medications...
  88. ncbi [Why this arrogance, Josef Milerad?]
    Gunnar A Olin
    Lakartidningen 100:254-5. 2003
  89. ncbi Tetanus: pathophysiology and management
    M E Ernst
    College of Pharmacy, University of Iowa, Iowa City 52242, USA
    Ann Pharmacother 31:1507-13. 1997
    ..To review the epidemiology, pathophysiology, clinical manifestations, diagnosis, and management of tetanus and its complications...
  90. pmc Case report: prescribing caution. When a simple disease isn't so simple
    Cremona Ticea
    University of Calgary, Alberta
    Can Fam Physician 49:176-7. 2003
  91. ncbi PD(X)MD: a new clinical information tool for patient care
    Patricia Tomasulo
    Ehrman Medical Library, New York University Medical Center, 550 1st Avenue, New York, NY 10016, USA
    Med Ref Serv Q 22:77-83. 2003
    ....
  92. ncbi [Where can we find French data for pharmacoepidemiology? A few thoughts]
    K Martin
    Rev Epidemiol Sante Publique 55:58-63. 2007
  93. ncbi Counseling regarding pregnancy--related drug exposures by family physicians in Ontario
    Jodi Goodwin
    Department of Paediatrics, Children s Hospital of Western Ontario, Children s Health Research Institute, University of Western Ontario, London, Canada
    Can J Clin Pharmacol 14:e58-69. 2007
    ..Women must receive accurate information, as unrealistic perception of teratogenic risk may lead to inadequate treatment of maternal disease or termination of otherwise wanted pregnancies...
  94. ncbi Mental health nursing students' relationships with the pharmaceutical industry
    Russell Ashmore
    Sheffield Hallam University, Faculty of Health and Wellbeing, Mundella House, Collegiate Crescent, S1 1WB, United Kingdom
    Nurse Educ Today 27:551-60. 2007
    ..The medical profession's relationship with the pharmaceutical industry (PI) has come under increased scrutiny in recent years, however little is known on the subject in mental health nursing...
  95. ncbi [Newly-developed drug information services provided by hospital pharmacists]
    Yasuhiko Hirota
    Department of Hospital Pharmacy, Kansai Medical University, Osaka 570 8507
    Rinsho Byori 51:341-6. 2003
    ..Optimal drug therapy is the goal for every patient. Together, using their respective knowledge bases, pharmacists and physicians could provide optimal drug therapy, benefiting both patients and the health care system...
  96. ncbi Quality of medication information available on retail pharmacy Web sites
    Malini Ghoshal
    RxLogic Inc, 2314 Dorrington Street E, Houston, TX 77030, USA
    Res Social Adm Pharm 2:479-98. 2006
    ..Although the quality of consumer medication information (CMI) in brick and mortar pharmacies has been reported to be suboptimal, little is known about the quality of CMI offered by pharmacy Web sites...
  97. ncbi Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable
    Adrian R Levy
    Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Department of Health Care and Epidemiology, University of British Columbia, Vancouver
    Healthc Pap 3:32-7; discussion 87-94. 2002
    ..The question of how to implement the recommendations remains to be elucidated, as does an evaluation of the trade-offs between costs and benefits of obtaining better information on cost-effectiveness...
  98. ncbi Preventing medication errors: an IOM Report
    Beth Partin
    Westlake Primary Care, Columbia, KY, USA
    Nurse Pract 31:8. 2006
  99. ncbi [The Brazilian Drug Information System--SISMED]
    C C Vidotti
    Centro Brasileiro de Informação sobre Medicamentos, Conselho Federal de Farmácia, Brasilia, DF 70093 900, Brasil
    Cad Saude Publica 16:1121-6. 2000
    ..Four training courses have been held, resulting in the rapid development of Brazil's national DIC network. Two national meetings of DIC professionals have helped strengthen the Brazilian Drug Information System...
  100. doi Paternal exposure and counselling: experience of a Teratology Information Service
    Marco De Santis
    Telefono Rosso Teratology Information Service, Department of Obstetrics and Gynaecology, Catholic University of Sacred Heart, Rome, Italy
    Reprod Toxicol 26:42-6. 2008
    ....
  101. pmc Information about a discontinued drug
    Joel Lexchin
    CMAJ 178:730. 2008

Research Grants81

  1. Antifolates as Antimalarial Drugs
    CAROL SIBLEY; Fiscal Year: 2003
    ..We think that this in depth understanding of antifolate action in the parasites will ensure that WR99210 will be developed as a useful drug for the long haul against P. falciparum and P. vivax. ..
  2. Targeted and Tailored Messages to Enhance Depression Care
    Richard Kravitz; Fiscal Year: 2009
    ..Then, in a randomized controlled trial conducted in primary care offices, the effects of the two programs on depression care and outcomes will be compared with each other and with a control group. ..
  3. Mechanisms of beta-blocker induced improvements in asthma
    RICHARD AGUSTIN BOND; Fiscal Year: 2010
    ..Using a murine antigen driven 3=(n' 0 moo +L' 0p., >_E Off' :.(n ECM (II :.. O-0 o-- (Q' 6C' 0-: ..
  4. Clinical Implications of Variation Among Medicare Formularies
    Chien Wen Tseng; Fiscal Year: 2007
    ....
  5. Spectrum of and Nutritional Risk Factors for FASD in Russia and Ukraine
    Christina Chambers; Fiscal Year: 2007
    ....
  6. Health Literacy and Cognitive Function among Older Adults
    Michael Wolf; Fiscal Year: 2007
    ..Exploratory analyses will also evaluate the efficacy of design strategies to improve health information materials. ..
  7. Optimizing NNRTI Doses in Patients with HIV and TB
    Terrence Blaschke; Fiscal Year: 2007
    ..The incidence of central nervous system adverse events (neuropsychological/mood), hepatotoxicity, skin reactions and immunologic and virological signs of treatment failure will be monitored and compared between arms. ..
  8. Improving Care for Comorbid Physical and Mental Illness
    Richard Kravitz; Fiscal Year: 2007
    ..abstract_text> ..
  9. RESEARCH ETHICS IN SCHIZOPHRENIA
    William Carpenter; Fiscal Year: 2007
    ....
  10. Facilitating Aftercare for Alcohol Detox Patients
    RICHARD BLONDELL; Fiscal Year: 2007
    ..The main outcome measures will be the initiation of aftercare (i.e. treatment/AA initiation) and percent days abstinent. ..
  11. Antifolates as Antimalarial Drugs
    CAROL SIBLEY; Fiscal Year: 2007
    ..We think that this in depth understanding of antifolate action in the parasites will ensure that WR99210 will be developed as a useful drug for the long haul against P. falciparum and P. vivax. ..
  12. Targeted and Tailored Messages to Enhance Depression Care
    Richard Kravitz; Fiscal Year: 2007
    ..Then, in a randomized controlled trial conducted in primary care offices, the effects of the two programs on depression care and outcomes will be compared with each other and with a control group. ..
  13. Reducing Cost-Related Medication Nonadherence in Persons with Diabetes
    Chien Wen Tseng; Fiscal Year: 2010
    ..If shown to be successful, the Prescribing Guide is practical and low-cost, and could easily be translated to other states, giving it tremendous potential to improve health nationwide. ..
  14. Comparative Safety and Effectiveness of Stimulants in Medicaid Youth with ADHD
    Almut G Winterstein; Fiscal Year: 2010
    ....
  15. Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and Outcome
    Julie Marie Donohue; Fiscal Year: 2010
    ....
  16. Targeted and Tailored Messages to Enhance Depression Care
    Richard L Kravitz; Fiscal Year: 2010
    ..Then, in a randomized controlled trial conducted in primary care offices, the effects of the two programs on depression care and outcomes will be compared with each other and with a control group. ..
  17. Enhanced Spanish Drug Label Design to Promote Patient Understanding and Use
    Michael S Wolf; Fiscal Year: 2010
    ..Findings gathered will inform anticipated next steps for a dissemination strategy. ..
  18. Mechanisms of beta-blocker induced improvements in asthma
    Richard Bond; Fiscal Year: 2009
    ..Using a murine antigen driven 3=(n' 0 moo +L' 0p., >_E Off' :.(n ECM (II :.. O-0 o-- (Q' 6C' 0-: ..
  19. A Team Model of Hypertension Care in African Americans
    Bonnie Svarstad; Fiscal Year: 2007
    ..The study is unique because it tests relatively simple and low cost interventions in the community pharmacy, an environment which is one of the most readily accessible components of the health care system. ..
  20. Antifolates as Antimalarial Drugs
    CAROL SIBLEY; Fiscal Year: 2006
    ..We think that this in depth understanding of antifolate action in the parasites will ensure that WR99210 will be developed as a useful drug for the long haul against P. falciparum and P. vivax. ..
  21. COGNITIVE EFFECTS OF SUBSTANCE USE IN NATIVE AMERICANS
    John Halpern; Fiscal Year: 2003
    ..Pope and other investigators at the Alcohol and Drug Abuse Research Center. This program will enable Dr. Halpern to become an experienced investigator, capable of designing and performing future studies independently. ..
  22. TREATMENT OF NEGATIVE SYMPTOMS & COGNITIVE IMPAIRMENTS
    William Carpenter; Fiscal Year: 2003
    ..The study will provide new information on the efficacy of d- cyclosporine and glycine for both persistent primary and secondary negative symptoms and its effect on cognitive functioning. ..
  23. DRUG RESISTANCE IN MALARIA
    CAROL SIBLEY; Fiscal Year: 2002
    ..When completed their experiments will provide a detailed understanding of the mutations that modify function of the Pf-DHFR and Pf-DHPS enzymes or sensitivity of the enzymes to antifolate drugs. ..
  24. Targeted and Tailored Messages to Enhance Depression Care
    Richard L Kravitz; Fiscal Year: 2010
    ..Then, in a randomized controlled trial conducted in primary care offices, the effects of the two programs on depression care and outcomes will be compared with each other and with a control group. ..
  25. Consumer Influences of Treatment of Depression
    Richard Kravitz; Fiscal Year: 2004
    ..e., should DTCA be further regulated?) while also contributing to our understanding of the social influences on diagnosis and treatment of depression in primary care settings. ..
  26. RISK FACTORS FOR PHENYTOIN TOXICITY
    Sean Hennessy; Fiscal Year: 2005
    ..abstract_text> ..
  27. RESEARCH ETHICS IN SCHIZOPHRENIA
    William Carpenter; Fiscal Year: 2003
    ..The proposed work will provide a major source of scientific data of relevance to the current debate on ethics of schizophrenia research. ..
  28. Comparative Safety and Effectiveness of Stimulants in Medicaid Youth with ADHD
    Almut Winterstein; Fiscal Year: 2009
    ....
  29. Observational Study of Delay in Heart Failure
    Robert Goldberg; Fiscal Year: 2007
    ..These data will be useful in the development of future educational and treatment strategies designed to improve outcomes in patients with heart failure. ..
  30. Physician-Patient Communication Project
    Derjung M Tarn; Fiscal Year: 2010
    ..Findings will be used to develop physician- and patient-targeted interventions to promote efficient, effective communication during office visits that maximize patient understanding and satisfaction. ..
  31. Health Literacy and Cognitive Function among Older Adults
    Michael Wolf; Fiscal Year: 2009
    ..Exploratory analyses will also evaluate the efficacy of design strategies to improve health information materials. ..
  32. Community Surveillance for Heart Failure
    Robert Goldberg; Fiscal Year: 2007
    ..The continued extension of this surveillance project will provide insights and guidance to public health and clinical efforts of HF and in monitoring trends in this newly emerging chronic disease. ..
  33. Pharmacotherapy for Minor Depression
    Robert Howland; Fiscal Year: 2004
    ..The results of this study will have profound public health implications by improving our understanding of the efficacy of SJW and standard antidepressants for the treatment of MinorD. ..
  34. Creighton Health Services Research Development Project
    Kimberly Galt; Fiscal Year: 2007
    ..Funding of this BRIC will facilitate the capacity needed to advance the Creighton University's health services research mission in a more rapid and sustainable fashion. ..